Effect of smoking status on inhibin-A in second-trimester prenatal screening for Down syndrome

2014 ◽  
Vol 34 (4) ◽  
pp. 406-407
Author(s):  
Wayne Huttly ◽  
Jonathan Bestwick ◽  
Nicholas Wald
Keyword(s):  
Down Syndrome ◽  
Prenatal Screening ◽  
Smoking Status ◽  
Second Trimester ◽  
Inhibin A

Elevated second trimester dimeric inhibin a levels identify down syndrome pregnancies

1997 ◽  
Vol 176 (1) ◽  
pp. S90
Author(s):  
K.D. Wenstrom ◽  
J. Owen ◽  
D.C. Chu ◽  
L. Boots
Keyword(s):  
Down Syndrome ◽  
Second Trimester ◽  
Inhibin A

Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies

1997 ◽  
Vol 177 (5) ◽  
pp. 992-996 ◽  
Author(s):  
Katharine D. Wenstrom ◽  
John Owen ◽  
D.C. Chu ◽  
Larry Boots
Keyword(s):  
Down Syndrome ◽  
Second Trimester ◽  
Inhibin A

Prenatal Screening Strategies for Down Syndrome: Many Options but Few Answers

1998 ◽  
Vol 4 (3) ◽  
pp. 229
Author(s):  
Euan M. Wallace
Keyword(s):  
Down Syndrome ◽  
Prenatal Screening ◽  
New South ◽  
South Australia ◽  
Nuchal Translucency ◽  
Second Trimester ◽  
Mental Handicap ◽  
South Wales ◽  
Screening Strategies ◽  
Serum Screening

Down syndrome is the single most common cause of severe mental handicap in Australia. Prenatal screening for Down syndrome is therefore an important component of modern antenatal care. However, while effective second trimester serum screening for Down syndrome has been available in Australia for almost a decade it appears that the majority of Australian women, particularly those outside South Australia and New South Wales, are still not offered it. Newer methods of screening have been recently described and are already being offered in routine clinical practice. These methods, including nuchal translucency, will afford results earlier in pregnancy than second trimester serum screening and so are attractive to women. However, available evidence suggests that nuchal translucency may not perform as well as second trimester serum screening and further evaluation of the newer screening strategies in an Australian population is urgently required. Alteration of practice prior to such an evaluation is simply not warranted at this time.

The Effect of Inhibin A on Prenatal Screening Results for Down Syndrome in the High Risk Czech Pregnant Women

2019 ◽  
Vol 65 (05/2019) ◽  
Author(s):  
Jaroslav Loucký ◽  
Silvie Bělášková ◽  
Richard Průša ◽  
Karel Kotaška
Keyword(s):  
Down Syndrome ◽  
High Risk ◽  
Pregnant Women ◽  
Prenatal Screening ◽  
Inhibin A

Improvement of second trimester prenatal screening after inclusion of inhibin a determination

2019 ◽  
Vol 493 ◽  
pp. S584
Author(s):  
A. Alonso Llorente ◽  
A. Gutierrez Samper ◽  
M. Fabre Estremera ◽  
A. Fernandez Gonzalez ◽  
M.A. Castillo Arce ◽  
...  
Keyword(s):  
Prenatal Screening ◽  
Second Trimester ◽  
Inhibin A

Incorporation of Inhibin-A in Second-Trimester Screening for Down Syndrome*

2003 ◽  
Vol 102 (2) ◽  
pp. 413 ◽  
Author(s):  
Terrence W. Hallahan ◽  
David A. Krantz ◽  
James N. Macri
Keyword(s):  
Down Syndrome ◽  
Second Trimester ◽  
Inhibin A ◽  
Second Trimester Screening ◽  
Trimester Screening
Sign in / Sign up

Export Citation Format

Share Document